Study finds "extraordinary" genetic diversity in tumors

03/7/2012 | Reuters

About two-thirds of genetic mutations in samples from primary tumors of kidney cancer patients were different from one another, even if they were taken from the same tumor, a British study revealed. Researchers also found even more genetic differentiation in biopsies of secondary tumors. The findings in the New England Journal of Medicine suggest that using samples from a primary tumor as a basis for treatment decisions may not be sufficient, researchers said.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC